AAViator GMP Platform
Enabling Technology for AAV-based Gene Therapy Manufacturing
CommercialActive
Key Facts
Indication
Enabling Technology for AAV-based Gene Therapy Manufacturing
Phase
Commercial
Status
Active
Company
About Mirus Bio
Mirus Bio is a long-established, private biotechnology company specializing in nucleic acid delivery (transfection) technologies. Its product portfolio, including the TransIT, VirusGEN, and AAViator platforms, serves both basic research and the rapidly growing clinical and commercial-scale manufacturing needs for viral vectors in gene therapy. With a strong publication record, extensive patent portfolio, and a shift towards GMP-grade products, the company is strategically positioned as an essential tools and reagents provider for the biopharmaceutical industry.
View full company profile